Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis

BACKGROUND: Infection with respiratory syncytial virus (RSV) is common among young children insured through Medicaid in the United States. Complete and timely dosing with palivizumab is associated with lower risk of RSV-related hospitalizations, but up to 60% of infants who receive palivizumab in Me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pediatr
Main Authors: Krilov, Leonard R, Masaquel, Anthony S, Weiner, Leonard B, Smith, David M, Wade, Sally W, Mahadevia, Parthiv J
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287588/
https://ncbi.nlm.nih.gov/pubmed/25308481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-14-261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados